The Illinois Biotechnology Industry Organization (iBIO) today announced the election of Glover (Très) O. Johnson to the board of directors.
Très Johnson is Vice President of Psychiatric Sales in the United States for Lundbeck, a global biopharmaceutical company specializing in psychiatric and neurological disorders based in Denmark with U.S. headquarters in Deerfield, Illinois.
Très has over 30 years of experience in the pharmaceutical industry and is a passionate advocate for a variety of health and social issues, including education, homelessness, mental illness and addiction. A board member of Triton Community College, Tres champions the value of community colleges in meeting the needs of lower-income families, people of color, and first-generation and ex-military students.
“iBIO is fortunate to have Très Johnson join our board,” said John Conrad, iBIO President & CEO, “The leadership and experience that Très will bring to our board will be a great benefit to our organization and community.”
“I’m honored to be named to the iBIO board and value the opportunity to add my perspective to important conversations around advancing our innovation economy and transforming lives,” Tres said. “I am deeply committed to diversifying the life sciences workforce and am excited to play a role in iBIO’s STEM education and programming.”
The Illinois Biotechnology Innovation Organization (iBIO) is a life sciences industry association that represents the nearly 88,000 life sciences employees at member companies, universities, service providers and venture firms. iBIO promotes the industry’s value to the public and policymakers; connects innovators to investment and talent; stimulates collaboration and fosters the next generation of innovators and entrepreneurs to transform patient lives through groundbreaking research and works to grow the Illinois economy.